Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close
News & Events »
Tillotts Pharma announces MHRA<sup>1</sup> approval of Entocort<sup>TM</sup> Capsules for Microscopic Colitis

Press Release

Tillotts Pharma announces MHRA1 approval of EntocortTM Capsules for Microscopic Colitis

PRESS RELEASE RHEINFELDEN, Switzerland, February 5th 2018 – Tillotts Pharma AG (“T[...] Read more »
Tillotts Pharma AG signs license agreement on antibody technology with Inven2

Press Release

Tillotts Pharma AG signs license agreement on antibody technology with Inven2

RHEINFELDEN, Switzerland, January 22, 2018 Inven2 AS (Inven2), a technology transfer an[...] Read more »
Tillotts Pharma successfully completes DCP<sup>1</sup> for Colpermin™ in Europe

News Press Release

Tillotts Pharma successfully completes DCP1 for Colpermin™ in Europe

Press Release RHEINFELDEN, Switzerland, Nov. 29 2017 – Tillotts Pharma AG (“Tillott[...] Read more »
Tillotts Pharma: Positive Results of Largest Phase III Clinical Trial of Mesalazine Induction Therapy Published

News Press Release

Tillotts Pharma: Positive Results of Largest Phase III Clinical Trial of Mesalazine Induction Therapy Published

PRESS RELEASE Not for distribution in Czech Republic, France, Ireland, Spain, Sweden and [...] Read more »
A small fish in the big pond

News Press Release

A small fish in the big pond

CEO Thomas A. Tóth von Kiskér and Head of HR Gabriella Schraner were interviewed for the[...] Read more »
Tillotts Pharma eröffnet neue Zweiniederlassung in Berlin

Press Release

Tillotts Pharma eröffnet neue Zweiniederlassung in Berlin

Tillotts Pharma eröffnet neue Zweigniederlassung in Berlin[...] Read more »
1 2 3 4 5